Becton Dickinson Infusion Therapy Systems, Inc.: FDA filings under this applicant name

FDA lists 36 510(k) clearances under the applicant name “Becton Dickinson Infusion Therapy Systems, Inc.” (first 1997, latest 2026), across 5 product codes in 4 review panels. Median 510(k) review time under this name: 90 days. Since 2017 the median was 103 days, against 135 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

Caduvo groups this applicant name under BD (Becton, Dickinson and Company), based on public ownership records.

510(k) clearances per year

YearClearancesMedian review days
20120—
2013143
20140—
2015272
2016161
2017151
20180—
20191103
20202113
20210—
2022130
20233147
20240—
20256122
20261268

Review time against the same product codes

Since 2017, 510(k)s cleared under the name Becton Dickinson Infusion Therapy Systems, Inc. took a median 103 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 135 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
FOZCatheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days3030
FPASet, Administration, Intravascular22
JKATubes, Vials, Systems, Serum Separators, Blood Collection22
DBYFab, Rhodamine, Antigen, Antiserum, Control11
DYBIntroducer, Catheter11

Review panels

Most recent Becton Dickinson Infusion Therapy Systems, Inc. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K252137BD Insyte™ IV CatheterFOZ2026-04-02268
K251422BD Saf-T-Intima™ Subcutaneous Catheter SystemFOZ2025-10-08154
K243403BD Nexiva™ Closed IV Catheter SystemFOZ2025-07-25267
K251155BD Cathena™ Safety IV CatheterFOZ2025-07-1188
K251654BD Insyte™ Autoguard™ Shielded IV Catheter, BD Insyte™ Autoguard™ BC Shielded IV Catheter and BD Insyte™ Autoguard™ BC Pro Shielded IV CatheterFOZ2025-06-2728
K250682BD Nexiva™ Diffusics™ Closed IV Catheter System and BD Nexiva™ Diffusics™ Closed IV Catheter System with BD MaxZero™ Needle-free ConnectorFOZ2025-06-0389
K241586PIVO™ Pro Needle-free Blood Collection DeviceJKA2025-02-27269
K233529BD Nexiva™ Diffusics™ Closed IV Catheter System with BD MaxZero™ Needle-free ConnectorFOZ2023-12-0129
K230865PIVO™ Pro Needle-free Blood Collection DeviceJKA2023-09-28183
K231239Nexiva™ Closed IV Catheter System with NearPort™ IV AccessFOZ2023-09-22147

26 earlier clearances. See the full list in Caduvo.

Recalls

15 product recalls in 7 recall events; 14 initiated in the last five years. Most recent: 2025-05-21.

32 product recalls in 8 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: Becton Dickinson Medical Systems (19), Becton Dickinson Infusion Therapy (6), Becton Dickinson & Company (4).

These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Parent company SEC filings

BECTON DICKINSON & CO (BDX): EDGAR filings, CIK 10795. Caduvo groups Becton Dickinson Infusion Therapy Systems, Inc. under BD (Becton, Dickinson and Company); the parent's SEC registrant is entered by hand for the group, not matched by name.

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under Becton Dickinson Infusion Therapy Systems, Inc.?

FDA lists 36 510(k) clearances under the applicant name “Becton Dickinson Infusion Therapy Systems, Inc.” (first 1997, latest 2026), across 5 product codes in 4 review panels. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Becton Dickinson Infusion Therapy Systems, Inc.?

The median time from FDA receipt to decision across 510(k)s cleared under the name Becton Dickinson Infusion Therapy Systems, Inc. is 90 days. Since 2017: 103 days, versus 135 days for all cleared 510(k)s in the same product codes.

Which FDA product codes appear under Becton Dickinson Infusion Therapy Systems, Inc.?

The most frequent FDA product codes under this applicant name are FOZ (Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days, 30); FPA (Set, Administration, Intravascular, 2); JKA (Tubes, Vials, Systems, Serum Separators, Blood Collection, 2).

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.

All FDA device companies · FDA product code lookup